ARC is a novel therapeutic approach against acetaminophen-induced hepatocellular necrosis.
about
A novel role for the apoptosis inhibitor ARC in suppressing TNFα-induced regulated necrosisPathophysiological significance of c-jun N-terminal kinase in acetaminophen hepatotoxicityNecroptosis: an emerging type of cell death in liver diseasesQuestions and controversies: the role of necroptosis in liver diseaseInteraction of ARC and Daxx: A Novel Endogenous Target to Preserve Motor Function and Cell Loss after Focal Brain Ischemia in MiceReceptor interacting protein kinase 1 mediates murine acetaminophen toxicity independent of the necrosome and not through necroptosis.The role of apoptosis repressor with a CARD domain (ARC) in the therapeutic resistance of renal cell carcinoma (RCC): the crucial role of ARC in the inhibition of extrinsic and intrinsic apoptotic signalling.Drug-Induced Liver Injury: Cascade of Events Leading to Cell Death, Apoptosis or NecrosisESCRT-0 dysfunction compromises autophagic degradation of protein aggregates and facilitates ER stress-mediated neurodegeneration via apoptotic and necroptotic pathways.Glycyrrhizin Protects against Acetaminophen-Induced Acute Liver Injury via Alleviating Tumor Necrosis Factor α-Mediated Apoptosis.Receptor interacting protein kinase 3 is a critical early mediator of acetaminophen-induced hepatocyte necrosis in mice.RIPK1 protects from TNF-α-mediated liver damage during hepatitis.Acute kidney injury in acute liver failure: a review.Apoptosis Repressor with Caspase Recruitment Domain Ameliorates Amyloid-Induced β-Cell Apoptosis and JNK Pathway Activation.Synthesis, Characterization, and DNA Binding Profile of a Macrocyclic β-Sheet Analogue of ARC Protein.The Receptor Interacting Protein Kinases in the Liver.The chemical inhibitors of cellular death, PJ34 and Necrostatin-1, down-regulate IL-33 expression in liver.
P2860
Q24321576-59F493A5-461F-4C5B-A261-64F2579DF175Q26799194-14D26896-8E00-4EF3-8B36-B33FD89787A2Q26849790-856840AA-F300-4778-A577-B92C833F51CDQ28072789-F651166A-6802-45CC-B90C-86DA0C42099FQ28595484-8183F15F-4499-4CF7-A552-9192ADBF643AQ30009153-207FCACB-C3A7-4F9F-862B-441C91B9F362Q33629783-8E5A90F8-3727-4D26-902B-692EE07BBCD1Q33755165-FD861520-E36F-405A-8E8B-4C9F778C5B3AQ36835648-61A8C31F-8460-4D1C-B098-6EB38774BE74Q36852508-C5FAE655-3360-45C4-A9F2-31BB8ED3AE53Q37216910-EF0C76BD-2E85-4A78-9011-1C4F65FC2CFDQ37603308-B7C620A9-C4CB-45BD-8AA3-7C9F5B33C50AQ38153420-C30B0A14-638B-45AC-B510-C176BA907B0FQ38669274-818D5BA4-30A5-4AE6-98A6-57C5AC6D148CQ40162731-A7E9BDF2-298A-4070-9EFE-5D8C18857DFBQ52689573-81EA7EDA-25A7-481D-A3EB-563BC2A7586BQ55066176-CEBDF03C-E785-4FD1-83E8-F9B193AA6196
P2860
ARC is a novel therapeutic approach against acetaminophen-induced hepatocellular necrosis.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh-hant
name
ARC is a novel therapeutic app ...... duced hepatocellular necrosis.
@en
ARC is a novel therapeutic app ...... duced hepatocellular necrosis.
@nl
type
label
ARC is a novel therapeutic app ...... duced hepatocellular necrosis.
@en
ARC is a novel therapeutic app ...... duced hepatocellular necrosis.
@nl
prefLabel
ARC is a novel therapeutic app ...... duced hepatocellular necrosis.
@en
ARC is a novel therapeutic app ...... duced hepatocellular necrosis.
@nl
P2093
P1476
ARC is a novel therapeutic app ...... duced hepatocellular necrosis.
@en
P2093
Ana D Mandić
Christian Trautwein
Felix Mehrhof
Gernot Sellge
Junfeng An
Matthias Endres
Sabrina L L Lee
Stefan Donath
P304
P356
10.1016/J.JHEP.2012.10.002
P577
2012-10-06T00:00:00Z